V

Verastem
D

VSTM

7.09000
USD
0.10
(1.43%)
مغلق
حجم التداول
28,829
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
315,551,269
أصول ذات صلة
A
ADMA
-0.390
(-2.29%)
16.630 USD
C
CTMX
0.00920
(1.39%)
0.66920 USD
E
EXEL
0.550
(1.43%)
39.140 USD
I
IMMP
0.02000
(1.14%)
1.77000 USD
I
IONS
-1.545
(-4.58%)
32.225 USD
M
MNOV
-0.10000
(-6.29%)
1.49000 USD
T
TGTX
0.810
(2.11%)
39.260 USD
المزيد
الأخبار المقالات

العنوان: Verastem

القطاع: Healthcare
الصناعة: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.